Hematology | Birth | 1 year | 2 years | 2½ years | 3 years (BMT +5 days) | 5 years (BMT +2 years) |
---|---|---|---|---|---|---|
*Outside the normal range of values. | ||||||
†Post-BMT transfusion values. | ||||||
Hb (g/dL) | 15.9 | — | 9.5* | 2.0* | 6.8† | 13.1 |
Ht (L/L) | 0.53 | — | 0.33 | 0.07* | — | 0.40 |
Reticulocytes (106/mL) | NT | — | 3.2 | <0.1* | — | 2.1 |
MCV (fL) | NT | — | 90 | 79 | — | 83.7 |
Platelets (106/mL) | 134 | — | 150 | 483 | 20† | 379 |
Leukocytes (106/mL) | 18.9 | — | 9.4 | 1.1* | 0.1 | 8.1 |
% neutrophils | 68 | — | 52 | 22 | — | 52 |
% monocytes | 6 | — | 10 | 8 | — | 6 |
% lymphocytes | 22 | — | 35 | 67 | — | 42 |
IgG | — | 11.5 | 9.6 | 5.2 | — | 11.3 |
IgA | — | 1.4 | 1.0 | 0.4 | — | 1.4 |
IgM | — | 1.0 | 0.7 | 0.3* | — | 1.3 |
Lymphocytes (106/mL) | — | 4.2 | 3.3 | 0.7* | — | 3.4 |
CD3+ T cells | — | — | — | 0.3* | — | 1.9 |
TcRαβ | — | — | — | 51% | — | — |
TcRγδ | — | — | — | 49% | — | — |
CD3+/4+ Th cells | — | — | — | 0.06* | — | 1.03 |
CD45RA | — | — | — | 7% | — | 81% |
CD45RO | — | — | — | 84% | — | 22% |
CD3+/8+ Tc cells | — | — | — | 0.1* | — | 0.74 |
CD45RA | — | — | — | 56% | — | 85% |
CD45RO | — | — | — | 42% | — | 14% |
CD19+ B cells | — | — | — | 0.2 | — | 1.11 |
CD16/56+ NK cells | — | — | — | 0.2 | — | 0.34 |